New Delhi: The Indian Council of Medical Research (ICMR)'s advisory on the usage of anti-malarial drug hydroxychloroquine (HCQ) as a preventive drug created a row last week, with a Lancet study seemingly contradicting its position. But there is a clear and ...
from Google Alert - health https://ift.tt/3d99OlS
via IFTTT
0 comments:
Post a Comment